App-Based learning may cut heart risk after attack
NCT ID NCT06548555
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether long-term digital education, like online lessons or app-based guidance, helps people who had a heart attack lower their LDL (bad) cholesterol more than standard care. Researchers followed 121 patients in the Czech Republic for 12 months. The goal was to see if digital tools improve cholesterol control and could be used broadly in heart disease prevention.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could show that digital education helps heart attack patients better manage cholesterol, leading to wider use of such programs.
What could go wrong
This was a small, completed study in one country, so results may not apply everywhere. It only measured cholesterol, not heart attacks or survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Brno-Bohunice, 625 00, Czechia
-
Novartis Investigative Site
České Budějovice, 370 01, Czechia
-
Novartis Investigative Site
Ostrava Poruba, 708 52, Czechia
-
Novartis Investigative Site
Prague, 12808, Czechia
-
Novartis Investigative Site
Prague, 150 30, Czechia